NJCBA STATEMENT ON PASSAGE OF MEDICAL MARIJUANA & CANNABIDIOL RESEARCH EXPANSION ACT

Trenton — New Jersey CannaBusiness Association (NJCBA) President Edmund DeVeaux issued the following statement today regarding passage of the federal Medical Marijuana and Cannabidiol Research Expansion Act, which expands research into cannabis-derived medications:

“Each day brings more positive developments in the cannabis cause. Expanding and actually encouraging research into cannabis-derived medications is a commonsense measure that will better the lives of countless individuals. Moreover, it is a great step forward in the continued normalization of the growth and usage of cannabis.

“Hopefully this is a sign of more positive developments to come, including passage of the SAFE Banking Act and removing cannabis as a Schedule 1 substance. In the meantime, we look forward to President Biden signing this legislation.”

About The New Jersey CannaBusiness Association

The NJCBA’s mission is to promote jobs and growth in a sustainable and responsible cannabis industry. Starting with the pioneers in the medical cannabis market to the emerging players in the adult-use space, the NJCBA’s focus is to make certain that decision-makers and regulators understand and respect the needs of the CannaBusiness community and that our community remain responsible corporate citizens.

###